In re: AH Liquidation, Inc.

District Court, D. Delaware·Decided September 24, 2025·No. 1:23-cv-00329·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

IN RE: : Chapter 11 : AH LIQUIDATION, INC., : Case No. 21-10883 (CTG) : Debtor. : (Jointly Administered) ______________________________________________ : : HE, INC., : Appellant, : v. : Civ. No. 23-329-JLH : AVADIM HOLDINGS INC., and : RELION HOLDINGS LLC, : : Appellees. : ______________________________________________________________________________ MEMORANDUM ORDER I. INTRODUCTION This dispute arises from the chapter 11 cases of the above-captioned debtors (“Debtors”) in connection with the Bankruptcy Court’s construction and enforcement of its order (A-077–A-115)1 (”Sale Order”) approving the sale of the Debtors’ assets to appellees Avadim Holdings, Inc. and Relion Holdings LLC (“Buyer”). Prior to their bankruptcy, the Debtors bought from appellant HE. Inc. (“HE”) U.S. Patent No. 6,358,516 (the “Patent”), as well as all of the intellectual property associated with the Patent that was not already included in the Patent (the “Proprietary Technical Information” or “PTI,” and together with the Patent, the “Patent IP”). When the Debtors filed for bankruptcy, the Patent IP became property of the estate. The Debtors then sold substantially all of their assets to the Buyer, including all of their intellectual property, unless specifically excluded.

1 The docket of the chapter 11 cases, captioned In re AH Liquidation, Inc., No. 21-10883 (CTG) (Bankr. D. Del.), is cited herein as “B.D.I. __.” The appendix (D.I. 8-1) to HE’s opening brief is cited herein as “A-_,” and the appendix (D.I. 10) to Buyer’s answering brief is cited herein as “SA-_.” The Sale Order approved this sale free and clear of any claims or encumbrances. One year later, HE sued the Buyer in the Southern District of Georgia for using the Patent IP. Buyer moved the Bankruptcy Court to enforce the Sale Order and determine that the Buyer owned the Patent IP free and clear of HE’s lawsuit. On March 9, 2023, the Bankruptcy Court entered an order (B.D.I. 555) (“Enforcement Order”) enforcing the Sale Order, and HE appealed. On February 12, 2025, the Court issued an Opinion (D.I. 13) and Order (D.I. 14) affirming the Enforcement Order. On February 26, 2025, HE filed the Motion for Rehearing (D.I. 15), which is

pending before the Court. II. BACKGROUND In 2002, HE obtained the Patent.2 In 2007, HE licensed the Patent to the Debtors’ predecessor Avadim, LLC.3 In 2013, HE sold the Patent to the Debtors.4 Three years later, following a series of disputes, the Debtors and HE entered into three contracts: (1) a Settlement Agreement, dated July 15, 2016 (the “Settlement Agreement”);5 (2) a Confidentiality Non-Use and Non-Disclosure Agreement, dated July 15, 2016 (the “Confidentiality Agreement”);6 and (3) the Assignments and Confirmation of Previous Assignments, dated July 18, 2016 (the “Assignment”).7 The Settlement Agreement superseded all prior agreements and became the operative

2 A-336.

3 Id.

4 A-28 (Settlement Agreement at Fourth Whereas Clause).

5 (A-28–A-50).

6 (A-52–A-67).

7 (A-69–A-75). agreement governing the Debtors’ and HE’s relationship.8 The Settlement Agreement reaffirmed the sale and transfer to the Debtors of HE’s “entire right, title, and interest in and to” the Patent, and further conveyed to the Debtors all of the Patent IP.9 HE thus broadly assigned to the Debtors everything it owned associated with topically applied formulations, “including, but not limited to, patents, trademarks, copyrights, domain names, web addresses, websites, personal sales, equipment, and proprietary business and technical information … reasonably related to topically applied formulations that may be used on people, other mammals, surfaces, and the like.”10 HE also

relinquished all rights in the Patent IP: Neither HE, Inc. nor N.R. Harod shall retain any rights whatsoever in the assets of HE, Inc. that are assigned under this Section 1 … or any rights or ownership whatsoever in the subject matter of this Settlement Agreement.11

In exchange, the Debtors agreed to pay consideration to HE, including cash in monthly installments.12 The Settlement Agreement provided that if the Debtors breached this obligation, the breach would “not result in termination of this Settlement Agreement, and the sole remedy of HE, Inc. and N.R. Harod [would] be in monetary damages.”13

8 A-29 (Settlement Agreement at Ninth Whereas Clause).

9 A-28 (Settlement Agreement at Fourth Whereas Clause).

10 A-29 (Settlement Agreement § 1) (emphasis added).

11 See also A-30 (Settlement Agreement § 1) (HE “retain[s] no ownership interest whatsoever in any subject matter reasonably related to topically applied formulations[.]”); A-33 (id. § 10) (“[T]he parties confirm that HE, Inc. has retained under this Settlement Agreement ownership of no rights or property whatsoever, other than with respect to any liabilities associated therewith, in any subject matter reasonably related to topically applied formulations[.]”).

12 A-32–A-33 (Settlement Agreement § 9(b)).

13 A-38 (Settlement Agreement § 23). The Debtors and HE also entered into the Confidentiality Agreement. Under that agreement, HE and its principals agreed not to disclose any confidential information, trade secrets, or other proprietary information relating to the Patent IP—that is, “relating to topically applied formulations that may be used on people, other mammals, surfaces, and the like, including but not limited to formulations coming within the scope of … U.S. Patent No. 6,358,516, and that may not be specifically enumerated in U.S. Patent No. 6,358,516.”14 The Confidentiality Agreement also transferred to the Debtors “all ownership interest that any of them may possess, individually or

collectively with HE, Inc., in the HE, Inc. Proprietary Information [and] . . . acknowledge[d] that none of them . . . retain[] any interest whatsoever in the HE, Inc. Proprietary Information” going forward.15 Finally, HE formally transferred the Patent IP by executing the Assignment. The Assignment relates to the entirety of the Patent IP, including the PTI, defined as: proprietary technical information associated with the said Harod U.S. Patent No. 6,358,516, including inventions, trade secrets, and the like information reasonably related to topically applied formulations that may be used on people, mammals, surfaces, and the like (“Proprietary Technical Information”)[.]16

The Assignment confirmed the transfer of the Patent, and conveyed the PTI from HE to Debtors: HE, Inc. has sold to Avadim LLC and by these presents does hereby confirm the sale, assignment, transference, and conveyance unto Avadim LLC as of March 4, 2013; and Avadim LLC has sold to ATI … the entire right, title, and interest, including the right to sue for past infringement, in Harod U.S. Patent No. 6,358,516…

The Parties further wish it known that for good and valuable consideration, the receipt and sufficiency of which is hereby

14 A-53 (Confidentiality Agreement § 1).

15 A-54 (Confidentiality Agreement § 4).

16 A-69 (Second Whereas Clauses) (emphasis added). acknowledged, Harod and HE, Inc., jointly and severally, have sold and by these presents do hereby confirm the sale, assignment, transference, and conveyance unto ATI, the entire right, title, and interest in the Proprietary Technical Information[.]17

The Debtors filed for bankruptcy in May 2021. As HE explains:18

The calendar year 2021 timeline was as follows: the Debtors filed their sale motion (D.I. 16) on June 1, the day after commencing their chapter 11 cases [A_001]; the Debtors filed the form of Sale Order containing Paragraph 44 on July 28 (D.I. 219) [A_002]; the Bankruptcy Court entered the Sale Order without a hearing on August 1 (D.I. 239) [A_003]; and the Debtors gave notice of the sale closing on August 17 (D.I.

Free access — add to your briefcase to read the full text and ask questions with AI

In re: AH Liquidation, Inc., (D. Del. 2025).

In re: AH Liquidation, Inc. (In re: AH Liquidation, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related